ENTPD1 and hematologic disorder: Furthermore, the preferential infiltration of adenosine-producing CD39+ Treg has been reported for solid tumors such as head and neck cancer (37), non-small cell lung cancer (38) and colorectal carcinomas (39) but also for hematological malignancies such as follicular lymphoma (40).